Research protocol for the Paraesophageal hernia symptom tool, a prospective multi-center cohort study to identify the need and threshold for surgery and assess the symptom response to surgery.


Journal

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus
ISSN: 1442-2050
Titre abrégé: Dis Esophagus
Pays: United States
ID NLM: 8809160

Informations de publication

Date de publication:
30 Sep 2023
Historique:
received: 17 11 2022
medline: 3 10 2023
pubmed: 9 5 2023
entrez: 9 5 2023
Statut: ppublish

Résumé

Large hiatus hernias with a significant paraesophageal component (types II-IV) have a range of insidious symptoms. Management of symptomatic hernias includes conservative treatment or surgery. Currently, there is no paraesophageal hernia disease-specific symptom questionnaire. As a result, many clinicians rely on the health-related quality of life questionnaires designed for gastro-esophageal reflux disease (GORD) to assess patients with hiatal hernias pre- and postoperatively. In view of this, a paraesophageal hernia symptom tool (POST) was designed. This POST questionnaire now requires validation and assessment of clinical utility. Twenty-one international sites will recruit patients with paraesophageal hernias to complete a series of questionnaires over a five-year period. There will be two cohorts of patients-patients with paraesophageal hernias undergoing surgery and patients managed conservatively. Patients are required to complete a validated GORD-HRQL, POST questionnaire, and satisfaction questionnaire preoperatively. Surgical cohorts will also complete questionnaires postoperatively at 4-6 weeks, 6 months, 12 months, and then annually for a total of 5 years. Conservatively managed patients will repeat questionnaires at 1 year. The first set of results will be released after 1 year with complete data published after a 5-year follow-up. The main results of the study will be patient's acceptance of the POST tool, clinical utility of the tool, assessment of the threshold for surgery, and patient symptom response to surgery. The study will validate the POST questionnaire and identify the relevance of the questionnaire in routine management of paraesophageal hernias.

Identifiants

pubmed: 37158194
pii: 7156866
doi: 10.1093/dote/doad028
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of International Society for Diseases of the Esophagus. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Nainika Menon (N)

Department of general surgery, Oxford University Hospitals National Health Service Foundation Trust, Oxford, UK.

Nadia Guidozzi (N)

Department of General Surgery, University of Witwatersrand, Johannesburg, South Africa.

Swathikan Chidambaram (S)

Department of Surgery and Cancer, Imperial College London, St Mary's Hospital, London, UK.

Aiysha Puri (A)

Department of Surgery and Cancer, Imperial College London, St Mary's Hospital, London, UK.

Viknesh Sounderajah (V)

Department of Surgery and Cancer, Imperial College London, St Mary's Hospital, London, UK.

Lorenzo Ferri (L)

Department of Surgery, McGill University Health Centre, Montreal, Quebec, Canada.

Ewen A Griffiths (EA)

Department of Surgery, Univeristy of Birmingham National Health Service Trust, Birmingham, UK.

Donald Low (D)

Department of Thoracic Surgery and Thoracic Oncology, Virginia Mason Medical Centre, Seattle, Washington, USA.

Nick Maynard (N)

Department of Surgery, Oxford Upper GI Centre, Churchill Hospital, Oxford University Hospitals National Health Service Foundation Trust, Oxford, UK.

Carmen Mueller (C)

Department of Thoracic Surgery and Thoracic Oncology, Virginia Mason Medical Centre, Seattle, Washington, USA.

Manuel Pera (M)

Section of Gastrointestinal Surgery, Department of Surgery, Hospital del Mar Medical Research Institute, Barcelona, Spain.

Mark I van Berge Henegouwen (MI)

Division of Surgery, UMC Amsterdam, Amsterdam.

David I Watson (DI)

Department of Surgery, College of Medicine and Public Health, Flinders University, Adelaide, Australia.

Giovanni Zaininotto (G)

Department of Surgery, Hospital SS Giovanni e Paolo, Venezia, Italy.

George B Hanna (GB)

Department of Surgery and Cancer, Imperial College London, St Mary's Hospital, London, UK.

Sheraz R Markar (SR)

Department of general surgery, Oxford University Hospitals National Health Service Foundation Trust, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH